Tianshi Group is a large-scale global enterprise group. Since its establishment, it has maintained a continual, stable, and rapid average annual growth rate of 170%. With its anchor business in advanced biotechnology, Tianshi is also involved in financing, real estate development, education, cultural exchanges, and modern logistics. Headquartered at the Henderson Center in Beijing, its production plants are located in the Wuqing New Technology Development Zone of Tianjin. Its total assets in China are valued at RMB 2.1 billion.

Tianshi Group, incorporated in 1995, was preceded by Tianshi Economic Development Co., Ltd., which was incorporated in 1992. The group started to venture into the international market in early 1998, and is now a participant in the global market place. As a result of seven years of arduous efforts, Tianshi has diversified its production line from a single product to various products, such as nutritional supplements, general food commodities, and medical equipment, totaling nearly 200 products. Its business now covers 170 countries and regions worldwide with branches rooted over 90 countries in the Americas, Europe, Asia, and their surrounding regions. It has established extensive strategic partnerships with more than 10 overseas enterprises in countries such as the United States, Japan, Germany and Malaysia. In China, Tianshi has registered wholly owned subsidiaries in 34 provinces and regions, with 1,800 outlets. Globally, Tianshi has seven million regular customers.

Based on its state-of-the-art biotechnology, Tianshi is committed to instilling traditional Chinese medicine and regimens. The quality of its products is further ensured by the importation of complete sets of automated equipment from Germany, Italy and the United States, which costs nearly RMB 100 million. The group obtained the ISO9001, 2000 authorization of the international quality system. All products manufactured and distributed within the United States have passed the quality tests of the FDA.